|
Volumn 47, Issue 5, 2001, Pages 429-436
|
The vitamin D3 analog, ILX-23-7553, enhances the response to Adriamycin and irradiation in MCF-7 breast tumor cells
|
Author keywords
Adriamycin; Apoptosis; Breast tumor cells; LLX 23 7553; Radiation
|
Indexed keywords
COLECALCIFEROL DERIVATIVE;
DNA FRAGMENT;
DOXORUBICIN;
ILX 237553;
SEOCALCITOL;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
COLECALCIFEROL;
DRUG DERIVATIVE;
ILX237553;
APOPTOSIS;
ARTICLE;
BREAST TUMOR;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
CELL COUNT;
CELL VIABILITY;
CHEMOSENSITIVITY;
CLONOGENESIS;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG CYTOTOXICITY;
DRUG POTENTIATION;
FEMALE;
HUMAN;
HUMAN CELL;
IONIZING RADIATION;
PRIORITY JOURNAL;
RADIOSENSITIVITY;
TUMOR CELL;
CELL CULTURE;
DRUG EFFECT;
METABOLISM;
RADIATION EXPOSURE;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BREAST NEOPLASMS;
CHOLECALCIFEROL;
DOXORUBICIN;
DRUG SYNERGISM;
FEMALE;
HUMANS;
TUMOR CELLS, CULTURED;
|
EID: 0034744476
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s002800000251 Document Type: Article |
Times cited : (66)
|
References (45)
|